ADUNNI WARD: Open Payments
NPI 1477217180 · LANSDOWNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 9 payments from 7 companies in 2025. Trend: 2023 $322 · 2024 $1,534 · 2025 $1,077
Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $237 |
| AstraZeneca Pharmaceuticals LP | 2 | $236 |
| Cipher Pharmaceuticals US LLC | 1 | $154 |
| Alnylam Pharmaceuticals Inc. | 1 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| PFIZER INC. | 1 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $83 |
Products named: Natroba, ONPATTRO, Descovy, BREZTRI, AUSTEDO XR, PREVNAR 20, Yeztugo, TZIELD.
Industry payments across PA — which companies pay providers there.
